Skip to main content
. 2019 Jun 16;2019:3808432. doi: 10.1155/2019/3808432

Figure 5.

Figure 5

Eya2 upregulates Bcl-2 via the AKT signaling pathway. (a) We identified positive associations between Eya2 mRNA and Bcl-2/MMP7 mRNA in 497 cases of prostate cancer (Pearson's correlation analysis, RNA-seq data was obtained from the TCGA database). (b) Protein levels of Bcl-2, p-AKT, and AKT in LNCaP cells treated with Eya2 and the AKT inhibitor, perifosine. Realtime PCR analysis of Bcl-2 mRNA in LNCaP cells treated with Eya2 plasmid and the AKT inhibitor, perifosine. Eya2 overexpression failed to upregulate levels of Bcl-2 mRNA and protein in cells treated with the AKT inhibitor.